Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409 |
Author(s) :
Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA |
Ref :
Diabet Med , 27 :1409 , 2010 |
Abstract : Forst_2010_Diabet.Med_27_1409 |
ESTHER : Forst_2010_Diabet.Med_27_1409 |
PubMedSearch : Forst_2010_Diabet.Med_27_1409 |
PubMedID: 21059094 |